During the past decade, University of Iowa Healthcare Cancer Services Quad Cities conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 35 clinical trials were completed, i.e. on average, 97.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 17 clinical trials were completed. i.e. 113.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Iowa Healthcare Cancer Services Quad Cities" #1 sponsor was "National Cancer Institute (NCI)" with 44 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Iowa Healthcare Cancer Services Quad Cities" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "NRG Oncology" with 3 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "University of Iowa Healthcare Cancer Services Quad Cities" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Breast Cancer AJCC v6 and v7" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Recurrent Breast Carcinoma" (5 trials) and "Stage IIIB Breast Cancer AJCC v7" (5 trials). Many other conditions were trialed in "University of Iowa Healthcare Cancer Services Quad Cities" in a lesser frequency.

Most popular intervention types in "University of Iowa Healthcare Cancer Services Quad Cities" are "Drug" (60 trials), "Other" (55 trials), "Biological" (33 trials), "Procedure" (15 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (17 trials), "Bevacizumab" (12 trials), "Computed Tomography" (12 trials) and "Biospecimen Collection" (10 trials). Other intervention names were less common.

The vast majority of trials in "University of Iowa Healthcare Cancer Services Quad Cities" are 61 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "University of Iowa Healthcare Cancer Services Quad Cities". undefined are not yet recruiting, 16 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in University of Iowa Healthcare Cancer Services Quad Cities, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Iowa Healthcare Cancer Services Quad Cities, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".